IRADIMED CORP (IRMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 30M 60M 90M Q4 '13: 11.3M Q1 '14: 12.3M Q2 '14: 14.2M Q3 '14: 15.5M Q4 '14: 15.7M Q1 '15: 19.1M Q2 '15: 22M Q3 '15: 26.4M Q4 '15: 31.6M Q1 '16: 33.6M Q2 '16: 35.8M Q3 '16: 35.3M Q4 '16: 32.5M Q1 '17: 28.7M Q2 '17: 24.4M Q3 '17: 22.4M Q4 '17: 23.1M Q1 '18: 25M Q2 '18: 26.9M Q3 '18: 28.8M Q4 '18: 30.4M Q1 '19: 31.8M Q2 '19: 33.6M Q3 '19: 36M Q4 '19: 38.5M Q1 '20: 38.8M Q2 '20: 36.3M Q3 '20: 34.1M Q4 '20: 31.7M Q1 '21: 32.3M Q2 '21: 35.3M Q3 '21: 38.5M Q4 '21: 41.8M Q1 '22: 44.9M Q2 '22: 47.8M Q3 '22: 50.3M Q4 '22: 53.3M Q1 '23: 56.5M Q2 '23: 59.9M Q3 '23: 63M Q4 '23: 65.6M Q1 '24: 67.7M Q2 '24: 69.5M Q3 '24: 71.3M Q4 '24: 73.2M Q1 '25: 75.2M Q2 '25: 77.6M Q3 '25: 80.5M Q4 '25: 83.8M Q1 '26: 86.3M Q2 '26: 86.3M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Gross Profit TTM

0 25M 50M 75M Q4 '13: 8.5M Q1 '14: 9.2M Q2 '14: 11M Q3 '14: 12.1M Q4 '14: 12.2M Q1 '15: 15M Q2 '15: 17.4M Q3 '15: 21.1M Q4 '15: 25.8M Q1 '16: 27.3M Q2 '16: 29.3M Q3 '16: 29M Q4 '16: 26.3M Q1 '17: 22.9M Q2 '17: 19M Q3 '17: 17.1M Q4 '17: 17.5M Q1 '18: 19.2M Q2 '18: 20.5M Q3 '18: 21.9M Q4 '18: 23.2M Q1 '19: 24.2M Q2 '19: 25.9M Q3 '19: 27.9M Q4 '19: 29.7M Q1 '20: 29.8M Q2 '20: 27.3M Q3 '20: 25.3M Q4 '20: 23.6M Q1 '21: 24.2M Q2 '21: 26.6M Q3 '21: 29.2M Q4 '21: 32M Q1 '22: 34.4M Q2 '22: 37.2M Q3 '22: 39.3M Q4 '22: 41.3M Q1 '23: 43.6M Q2 '23: 45.7M Q3 '23: 48M Q4 '23: 50.2M Q1 '24: 51.8M Q2 '24: 53.6M Q3 '24: 55M Q4 '24: 56.4M Q1 '25: 57.8M Q2 '25: 59.8M Q3 '25: 62.1M Q4 '25: 64.3M Q1 '26: 66.3M Q2 '26: 65.5M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Income TTM

-10M 0 10M 20M 30M Q4 '13: 2.8M Q1 '14: 2.7M Q2 '14: 3.5M Q3 '14: 3.6M Q4 '14: 3.1M Q1 '15: 4.5M Q2 '15: 5.6M Q3 '15: 8.4M Q4 '15: 11.5M Q1 '16: 12.7M Q2 '16: 13.4M Q3 '16: 12.8M Q4 '16: 10.9M Q1 '17: 7.2M Q2 '17: 4.2M Q3 '17: 1.8M Q4 '17: 1.3M Q1 '18: 2.6M Q2 '18: 4M Q3 '18: 5.2M Q4 '18: 6M Q1 '19: 6.4M Q2 '19: 7.1M Q3 '19: 8.2M Q4 '19: 8.6M Q1 '20: 7.9M Q2 '20: 2.6M Q3 '20: 831.8K Q4 '20: -756.1K Q1 '21: 283.7K Q2 '21: 5.1M Q3 '21: 7.4M Q4 '21: 9.8M Q1 '22: 11.1M Q2 '22: 13.4M Q3 '22: 14.5M Q4 '22: 15.6M Q1 '23: 16.6M Q2 '23: 17.4M Q3 '23: 19.1M Q4 '23: 20M Q1 '24: 20.8M Q2 '24: 21.4M Q3 '24: 21.3M Q4 '24: 22M Q1 '25: 22.6M Q2 '25: 23.8M Q3 '25: 24.9M Q4 '25: 26.1M Q1 '26: 28M Q2 '26: 27.6M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income TTM

0 9M 18M 27M Q4 '13: 1.9M Q1 '14: 1.8M Q2 '14: 2.3M Q3 '14: 2.3M Q4 '14: 2.1M Q1 '15: 3M Q2 '15: 3.8M Q3 '15: 5.4M Q4 '15: 7.5M Q1 '16: 8.3M Q2 '16: 8.8M Q3 '16: 8.5M Q4 '16: 7.2M Q1 '17: 4.7M Q2 '17: 2.8M Q3 '17: 1.5M Q4 '17: 499.8K Q1 '18: 1.6M Q2 '18: 2.6M Q3 '18: 4.8M Q4 '18: 6.3M Q1 '19: 7.3M Q2 '19: 8M Q3 '19: 8.1M Q4 '19: 9.6M Q1 '20: 9.6M Q2 '20: 5.4M Q3 '20: 4M Q4 '20: 1.4M Q1 '21: 986.6K Q2 '21: 4.6M Q3 '21: 6.1M Q4 '21: 9.3M Q1 '22: 10.4M Q2 '22: 12.2M Q3 '22: 13M Q4 '22: 12.8M Q1 '23: 13.7M Q2 '23: 14.7M Q3 '23: 16.3M Q4 '23: 17.2M Q1 '24: 17.9M Q2 '24: 18.6M Q3 '24: 18.6M Q4 '24: 19.2M Q1 '25: 19.8M Q2 '25: 20.7M Q3 '25: 21.2M Q4 '25: 22.5M Q1 '26: 23.6M Q2 '26: 23.1M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue TTM

0 8M 16M 24M Q4 '13: 2.9M Q1 '14: 3M Q2 '14: 3.1M Q3 '14: 3.4M Q4 '14: 3.4M Q1 '15: 4.1M Q2 '15: 4.6M Q3 '15: 5.3M Q4 '15: 5.8M Q1 '16: 6.2M Q2 '16: 6.5M Q3 '16: 6.4M Q4 '16: 6.2M Q1 '17: 5.8M Q2 '17: 5.3M Q3 '17: 5.2M Q4 '17: 5.6M Q1 '18: 5.9M Q2 '18: 6.4M Q3 '18: 6.9M Q4 '18: 7.2M Q1 '19: 7.6M Q2 '19: 7.7M Q3 '19: 8.1M Q4 '19: 8.8M Q1 '20: 9M Q2 '20: 9M Q3 '20: 8.8M Q4 '20: 8.1M Q1 '21: 8.1M Q2 '21: 8.7M Q3 '21: 9.2M Q4 '21: 9.8M Q1 '22: 10.5M Q2 '22: 10.6M Q3 '22: 11M Q4 '22: 12M Q1 '23: 12.8M Q2 '23: 14.2M Q3 '23: 15M Q4 '23: 15.4M Q1 '24: 15.9M Q2 '24: 15.8M Q3 '24: 16.3M Q4 '24: 16.9M Q1 '25: 17.3M Q2 '25: 17.9M Q3 '25: 18.5M Q4 '25: 19.5M Q1 '26: 20M Q2 '26: 20.8M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Cash Flow TTM

0 10M 20M 30M Q2 '14: 3.2M Q3 '14: 4.3M Q4 '15: 7.6M Q1 '16: 9M Q2 '16: 8.7M Q3 '16: 9.7M Q4 '16: 9.4M Q1 '17: 6.8M Q2 '17: 5.8M Q3 '17: 4.2M Q4 '17: 3.4M Q1 '18: 5.2M Q2 '18: 6.4M Q3 '18: 5.2M Q4 '18: 7.4M Q1 '19: 6.5M Q2 '19: 7.4M Q3 '19: 9.8M Q4 '19: 10.2M Q1 '20: 10.8M Q2 '20: 9.1M Q3 '20: 7.3M Q4 '20: 5.8M Q1 '21: 5.6M Q2 '21: 8.3M Q3 '21: 10.4M Q4 '21: 11.3M Q1 '22: 11.7M Q2 '22: 9.8M Q3 '22: 10.4M Q4 '22: 10M Q1 '23: 13.3M Q2 '23: 15.1M Q3 '23: 12.6M Q4 '23: 13.5M Q1 '24: 12.7M Q2 '24: 15.8M Q3 '24: 23.5M Q4 '24: 25.6M Q1 '25: 26M Q2 '25: 27.1M Q3 '25: 25M Q4 '25: 24.9M Q1 '26: 28.9M Q2 '26: 27.1M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Free Cash Flow TTM

0 9M 18M 27M Q2 '14: 2.9M Q3 '14: 3.7M Q4 '15: 7.4M Q1 '16: 8.6M Q2 '16: 8.1M Q3 '16: 9.1M Q4 '16: 8.6M Q1 '17: 6M Q2 '17: 5M Q3 '17: 3.4M Q4 '17: 2.6M Q1 '18: 4.6M Q2 '18: 5.9M Q3 '18: 5M Q4 '18: 7.1M Q1 '19: 6.2M Q2 '19: 7.2M Q3 '19: 9.6M Q4 '19: 9.9M Q1 '20: 10.3M Q2 '20: 8.5M Q3 '20: 6.7M Q4 '20: 5.4M Q1 '21: 5.2M Q2 '21: 8M Q3 '21: 9.9M Q4 '21: 10.8M Q1 '22: 11.2M Q2 '22: 9.2M Q3 '22: 9.7M Q4 '22: 9.2M Q1 '23: 6.2M Q2 '23: 8.1M Q3 '23: 5.4M Q4 '23: 6M Q1 '24: 11.4M Q2 '24: 13.6M Q3 '24: 17.8M Q4 '24: 17.6M Q1 '25: 14.6M Q2 '25: 14.2M Q3 '25: 14.8M Q4 '25: 17.2M Q1 '26: 24.5M Q2 '26: 25.1M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q2 '13: 8.5M Q3 '13: 8.7M Q1 '14: 8.9M Q2 '14: 8.9M Q3 '14: 11.3M Q1 '15: 12M Q2 '15: 12.1M Q3 '15: 12.4M Q1 '16: 12.3M Q2 '16: 12M Q3 '16: 11.9M Q1 '17: 10.7M Q2 '17: 11.7M Q3 '17: 11.6M Q1 '18: 11.9M Q2 '18: 12M Q3 '18: 12.2M Q1 '19: 12.2M Q2 '19: 12.2M Q3 '19: 12.3M Q1 '20: 12.4M Q2 '20: 12.1M Q3 '20: 12.5M Q1 '21: 12.5M Q2 '21: 12.6M Q3 '21: 12.6M Q1 '22: 12.7M Q2 '22: 12.6M Q3 '22: 12.6M Q1 '23: 12.7M Q2 '23: 12.7M Q3 '23: 12.7M Q1 '24: 12.7M Q2 '24: 12.8M Q3 '24: 12.8M Q1 '25: 12.8M Q2 '25: 12.8M Q3 '25: 12.9M Q1 '26: 12.9M Q2 '26: 12.9M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.70 1.40 2.10 Q4 '13: 0.22 Q1 '14: 0.21 Q2 '14: 0.25 Q3 '14: 0.24 Q4 '14: 0.21 Q1 '15: 0.27 Q2 '15: 0.31 Q3 '15: 0.44 Q4 '15: 0.60 Q1 '16: 0.67 Q2 '16: 0.71 Q3 '16: 0.69 Q4 '16: 0.61 Q1 '17: 0.40 Q2 '17: 0.24 Q3 '17: 0.13 Q4 '17: 0.04 Q1 '18: 0.13 Q2 '18: 0.21 Q3 '18: 0.39 Q4 '18: 0.52 Q1 '19: 0.60 Q2 '19: 0.66 Q3 '19: 0.66 Q4 '19: 0.78 Q1 '20: 0.77 Q2 '20: 0.43 Q3 '20: 0.32 Q4 '20: 0.11 Q1 '21: 0.08 Q2 '21: 0.37 Q3 '21: 0.48 Q4 '21: 0.74 Q1 '22: 0.83 Q2 '22: 0.97 Q3 '22: 1.04 Q4 '22: 1.03 Q1 '23: 1.10 Q2 '23: 1.17 Q3 '23: 1.30 Q4 '23: 1.36 Q1 '24: 1.41 Q2 '24: 1.46 Q3 '24: 1.46 Q4 '24: 1.50 Q1 '25: 1.55 Q2 '25: 1.62 Q3 '25: 1.65 Q4 '25: 1.75 Q1 '26: 1.83 Q2 '26: 1.79 Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.